Prof. Dr. Syed Khurram Gardezi

Syed Khurram Gardezi

Prof. Dr. Syed Khurram Gardezi

Consultant Cardiologist in Heart Failure, Cardio-Oncology, Cardiac MRI and Cardiomyopathy
Sheikh Shakhbout Medical City
Clinical Associate Professor in Cardiology
College of Medical & Health Sciences, Khalifa University
Abu Dhabi, UAE

With over fifteen years of experience in cardiovascular medicine, Dr Gardezi is a Clinical Associate Professor in Cardiology and a Consultant Cardiologist at Sheikh Shakhbout Medical City (SSMC) in the UAE. He is board certified by the Joint Royal College of Physicians Training Board (JRCPTB) and the General Medical Council (GMC) in the United Kingdom and holds a Certificate of Completion of Training (CCT) in Cardiovascular Medicine from the Royal College of Physicians. Dr Gardezi is a fellow of many worlds leading prestigious institutions including the Royal College of Physicians UK (FRCP Glasgow), the American College of Cardiology USA (FACC) as well as the Society of Cardiovascular Magnetic Resonance USA (FSCMR). Dr Gardezi specializes in advanced heart failure, cardiac MRI, cardio-oncology, cardiomyopathy, and pulmonary hypertension.


Dr Gardezi completed his training in Cardiology at the world renowned prestigious centres in London including Royal Brompton Hospital, Harefield Hospital, Imperial College Healthcare Trust, and Guys and St Thomas Hospitals. Dr Gardezi worked as a Consultant Cardiologist at the prestigious Guy’s & St Thomas Hospitals NHS Foundation trust before relocating to UAE. Dr Gardezi has a strong research background, having completed a Master of Science by Research in Cardiovascular Science from the prestigious University of Oxford, where he investigated the epidemiology and pathophysiology of atrial fibrillation and valvular heart disease. He has published multiple papers in high impact peer-reviewed journals and presented at national and international conferences. Additionally. Dr Gardezi is a passionate educator and his mission is to advance the field of cardiology and improve the outcomes and quality of life of patients with cardiovascular diseases.

Emirates Society for Rheumatology Annual Meeting 2026